Latest News & Features
Biotechnology
The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain. 6 April 2021
Medtech
Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi 1 April 2021
Americas
The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office. 1 April 2021
Biotechnology
Amgen v Sanofi continues the Federal Circuit’s trend of undermining certain antibody claims, explains Benjamin Pelletier of Haynes and Boone. 1 April 2021
Medtech
In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies. 30 March 2021
Europe
Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics. 30 March 2021
Big Pharma
The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels. 29 March 2021
Americas
The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes. 26 March 2021
Big Pharma
The US Supreme Court has denied a petition from Argentum Pharmaceuticals to review a Federal Circuit ruling covering a multiple sclerosis treatment patent. 25 March 2021
Americas
In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing. 25 March 2021